TIVC (Tivic Health Systems) Long-Term Capital Lease Obligation : $0.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Long-Term Capital Lease Obligation?

Tivic Health Systems's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.00 Mil.

Tivic Health Systems's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.37 Mil) to Dec. 2023 ($0.18 Mil) and declined from Dec. 2023 ($0.18 Mil) to Dec. 2024 ($0.00 Mil).

Tivic Health Systems Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tivic Health Systems's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems Long-Term Capital Lease Obligation Chart

Tivic Health Systems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.55

0.37

0.18

Tivic Health Systems Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial														0.14	-	-	-	-

Tivic Health Systems (NAS:TIVC) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tivic Health Systems Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tivic Health Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

47685 Lakeview Boulevard, Fremont, CA, USA, 94538

Website

https://www.tivichealth.com

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Executives

Sheryle Bolton	director	55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria	director	C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst	director, officer: Chief Executive Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein	officer: Chief Scientific Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia	officer: Chief Operating Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach	officer: Interim CFO	25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler	director	C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai	officer: Chief Financial Officer	C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude	10 percent owner	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz	officer: Chief Financial Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025